[O32] Oral 32 ART-5 | IFFS2025 / JSRM70

詳細検索

セッション詳細

Oral

[O32]Oral 32 ART-5

2025年4月29日(火) 14:00 〜 14:54

Hall B5-2

Chair(s): Yasushi Kawano (Japan), Yingying Qin (China)

14:00 〜 14:09

[O32-1]Withdrawn

14:09 〜 14:18

[O32-2]Novel Non-Invasive AI Model for Blastocyst Ploidy Prediction Using Time-Lapse Imaging Demonstrates Clinical Efficacy in Embryo Selection

^○Akihiro Yanai¹, Akihito Horie^{1 2}, Azusa Sakurai¹, Sachi Imakita¹, Mitsuhiro Nakamura¹, Asami Ikeda¹, Shimpei Shitanaka¹, Tsutomu Ohara¹, Yoshimi Kitawaki¹, Asuka Okunomiya¹, Masaki Mandai¹ (1.Department of Gynecology and Obstetrics, Kyoto University, 2.Department of Obstetrics and Gynecology, MMedical Research Institute KITANO HOSPITAL, PIIF Tazuke-kofukai)

14:18 〜 14:27

[O32-3]AI-Powered Embryo Prioritization System Enhances Clinical Outcomes in Frozen-Thawed Embryo Transfer Cycles

^○Sunny Sun^1,2, Yen-An Tang^{1 2 3}, Chun-Wei Chien^{1 2}, Hsien-An Pan⁴ (1.College of Medicine, National Cheng Kung University, Institute of Molecular Medicine, 2.Innovation Headquarters, National Cheng Kung University, Center for Genomic Medicine, 3.Business Development, AB DigiHealth Inc., 4.IVF center,, AN-AN Women and Children Center)

14:27 〜 14:36

[O32-4]The PAI-1 4G/5G polymorphism and its association with the risk of repeated implantation failure in a Korean population

^○Young Min Choi^1,2, Hwa Young Choi³, Min A Hong², Soo Jin Chae⁴ (1.Fertility Center, Grace Hospital, 2.Department of Obstetrics and Gynecology, Seoul National University College of Medicine, 3.Maria Fertility Hospital, 4.Iora Women's Clinic)

14:36 〜 14:45

[O32-5]Conflicting evidence of intrauterine immunotherapy in recurrent implantation failure lies in the flawed non-randomized trials: a meta-analysis

^○Ezri Chow¹, Elean To², Tony K. F. Chow³ (1.Public Fertility Care, The Royal Women's Hospital, 2.Royal Australian College of General Practitioners, 3.Australian & New Zealand College of Anaesthetists)

14:45 〜 14:54

[O32-6]Impact of the first blastocyst vitrification storage duration on pregnancy and neonatal outcomes in preimplantation genetic testing for aneuploidy on vitrifed unbiopsied blastocysts

^○Qian Zhang¹, Kexin Cao^{1 2 3 4 5 6 7}, Hong Chen^{1 2 3 4 5 6 7}, Shiheng Zhu^{1 2 3 4 5 6 7}, Xinyu Liu^{1 2 3 4 5 6 7}, Wenyu Liu^{1 2 3 4 5 6 7}, Min Su^{1 2 3 4 5 6 7}, Chunzi Lyu^{1 2 3 4 5 6 7}, Wei Zhou^{1 2 3 4 5 6 7}, Tianxiang Ni^{1 2 3 4 5 6 7}, Junhao Yan^{1 2 3 4 5 6 7} (1.Center for Reproductive Medicine, Institute of Women, Children and Reproductive Health, Shandong University, 2.National Research Center for Assisted Reproductive Technology and Reproductive Genetics, Shandong University, 3.Key Laboratory of Reproductive Endocrinology (Shandong University), Ministry of Education, 4.Shandong Technology Innovation Center for Reproductive Health, Jinan, Shandong, 5.Shandong Provincial Clinical Research Center for Reproductive Health, 6.ng Provincial Clinical Research Center for Reproductive Health, 7.Research Unit of Gametogenesis and Health of ART-Offspring, Chinese Academy of Medical Sciences (No.2021RU001))

カテゴリ一覧へ戻る